ADIAL PHARMACEUTICALS, INC. - ADIL
Insiders (Form 4) · last 180 days · showing up to 200 transactions
· Form 144 is shown in the SEC filings tab
Visible: 0
Transaction codes:
P = Open-market purchase ·
S = Open-market sale ·
A = Grant/award ·
M = Exercise/conversion of derivative ·
G = Gift ·
F = Tax withholding ·
J = Other ·
A/D:
A = Acquired (buy/receive) ·
D = Disposed (sell/give)
| Filed | Owner | Title | Code | A/D | Shares | Price | Value | Shares after | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Jul 16, 2026 | — | P | A | 1,233.0 | 2.75 | 3,390.75 | 388,308.0 | View | |
| Jul 16, 2026 | — | P | A | 2,000.0 | 2.65 | 5,300.0 | 387,075.0 | View | |
| Jul 13, 2026 | — | P | A | 1,700.0 | 2.7 | 4,590.0 | 385,075.0 | View | |
| Jul 13, 2026 | — | P | A | 10,053.0 | 2.79 | 28,047.87 | 383,375.0 | View | |
| Jul 01, 2026 | — | P | A | 25,000.0 | 2.6 | 65,000.0 | 373,322.0 | View | |
| Jun 16, 2026 | Chief Development Officer | A | A | 232,417.0 | 0.0 | 0.0 | 232,417.0 | View | |
| Jun 16, 2026 | Chief Development Officer | A | A | 101.3 | — | — | 1,923.43 | View | |
| Jun 16, 2026 | Chief Development Officer | A | A | 1,822.13 | — | — | 1,822.13 | View | |
| Jun 16, 2026 | Chief Development Officer | A | A | 232,417.0 | 0.0 | 0.0 | 297,491.0 | View | |
| Jun 16, 2026 | Chief Development Officer | A | A | 3,427.0 | — | — | 3,427.0 | View | |
| Jun 16, 2026 | Chief Development Officer | A | A | 61,647.0 | — | — | 61,647.0 | View | |
| Jun 16, 2026 | — | P | A | 36,378.0 | 2.7489 | 99,999.48 | 36,378.0 | View | |
| Apr 09, 2026 | Chief Operating Officer | A | A | 26,510.0 | 0.0 | 0.0 | 26,523.0 | View | |
| Apr 09, 2026 | — | A | A | 9,185.0 | 0.0 | 0.0 | 9,185.0 | View | |
| Apr 09, 2026 | — | A | A | 9,185.0 | 0.0 | 0.0 | 9,213.0 | View | |
| Apr 09, 2026 | Chief Financial Officer | A | A | 17,325.0 | 0.0 | 0.0 | 17,325.0 | View | |
| Apr 09, 2026 | — | A | A | 9,185.0 | 0.0 | 0.0 | 9,185.0 | View | |
| Apr 09, 2026 | Chief Executive Officer | A | A | 37,985.0 | 0.0 | 0.0 | 40,417.0 | View |